Table: Aska Pharmaceutical -6-MTH group results

ASKA Pharmaceutical Holdings

07/11/2016 06:00

Nov 7 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             24.32               21.11            48.00     
                 (+15.2 pct)         (-9.0 pct)       (+11.1 pct)  
  Operating          1.33              565 mln            1.80     
                (+135.6 pct)         (-47.1 pct)      (+40.3 pct)  
  Recurring          1.46              688 mln            2.00     
                (+111.4 pct)         (-41.5 pct)      (+31.4 pct)  
  Net                1.28              395 mln            1.70     
                (+222.2 pct)         (-52.6 pct)     (+142.5 pct)  
  EPS             45.67 yen           14.21 yen        60.84 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div         7.00 yen            7.00 yen                     
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T  
  ((Tokyo Headline News Desk +813 6441 1812))